2020-2025 Global Nuclear Medicine-Radiopharmaceuticals Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

SKU ID : Maia- 17273857

Publishing Date : 26-Jan-2021

No. of pages : 131

PRICE
3360
6720

  • Nuclear Medicines are primarily drugs that contain radioactive elements for radionuclide-emitting ionizing radiations. Their core application lies in the diagnosis and treatment of various diseases that conventional medicines fail to achieve. Radiopharmaceuticals are unique as they are used to directly target specific organs sites in the body where the drug can emit radiations. These radiations are then captured by gamma cameras placed in proximity of the patient. The radiation dose in these pharmaceuticals is kept as low as possible to avoid the side effects of radiation exposure.
    This report elaborates the market size, market characteristics, and market growth of the Nuclear Medicine-Radiopharmaceuticals industry, and breaks down according to the type, application, and consumption area of Nuclear Medicine-Radiopharmaceuticals. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

    In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Nuclear Medicine-Radiopharmaceuticals in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
    In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

    Key players in the global Nuclear Medicine-Radiopharmaceuticals market covered in Chapter 13:
    Alliance Medical
    Siemens Healthcare
    Lantheus Medical Imaging Inc
    Avid Radiopharmaceuticals
    Actinium Pharmaceuticals Inc
    Advanced Medical Isotope Corporation
    Nordion, Inc.
    Peregrine Pharmaceuticals, Inc.
    GE Healthcare
    Alseres Pharmaceuticals, Inc
    Immunomedics, Inc.
    Jubilant Pharma
    Ion Beam Applications S.A
    Mallinckrodt Pharmaceuticals
    Medi-Radiopharma Ltd
    Triad Isotopes, Inc.
    Bracco Imaging S.p.A
    Cardinal Health, Inc
    Bayer HealthCare Medical Care
    Positron Corporation

    In Chapter 6, on the basis of types, the Nuclear Medicine-Radiopharmaceuticals market from 2015 to 2025 is primarily split into:
    Diagnostic Medicine
    Therapeutic Medicine

    In Chapter 7, on the basis of applications, the Nuclear Medicine-Radiopharmaceuticals market from 2015 to 2025 covers:
    SPECT
    PET
    Therapeutic

    Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
    United States
    Europe
    China
    Japan
    India

    Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
    North America (Covered in Chapter 8)
    United States
    Canada
    Mexico
    Europe (Covered in Chapter 9)
    Germany
    UK
    France
    Italy
    Spain
    Others
    Asia-Pacific (Covered in Chapter 10)
    China
    Japan
    India
    South Korea
    Southeast Asia
    Others
    Middle East and Africa (Covered in Chapter 11)
    Saudi Arabia
    UAE
    South Africa
    Others
    South America (Covered in Chapter 12)
    Brazil
    Others

    Years considered for this report:


    Historical Years:

    2015-2019

    Base Year:

    2019

    Estimated Year:

    2020

    Forecast Period:

    2020-2025

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports